Non-small cell lung cancer is associated with poorer prognosis in older patients with IPF

Non-small cell lung cancer is associated with poorer prognosis in older patients with IPF

September 04, 2019

The researchers at the Icahn School of Medicine at Mount Sinai has stated that non-small cell lung cancer is associated with poorer prognosis and has a unique presentation in elderly patients with idiopathic pulmonary fibrosis.

One of the most interesting observations was that the rate of treatment for advanced cancer was lower in patients with lung fibrosis and lung cancer compared with those with lung cancer without lung fibrosis,” said author Charles Powell, MD, system chief of the division of pulmonary, critical care and sleep medicine at the Mount Sinai Health System and chief executive officer of the Mount Sinai-National Jewish Health Respiratory Institute. He further added, “However, we do know that even though patients with advanced stage lung cancer have relatively low survival rates, treatment does improve length and quality of life.”

Source: Icahn School of Medicine at Mount Sinai

Author : Meha Prasad

Tags :

Healthcare
x

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy and Cookie Policy. By continuing to use this site or closing this box, you consent to our use of cookies! Accept